Siendo miembro usted podrá ver nuestros videos educativos y editoriales, realizar búsquedas en nuestro sitio web, descargar diapositivas, participar en discusiones, recibir nuestros boletines de noticias y mucho más.
PARTNER, RIFLE, TWENTE, transcatheter valves, novel DES, and renal denervation — Drs. Worthley and Meredith give their take on the hot topics for the interventionalist.
Stroke rates are higher with transcatheter aortic-valve implantation vs surgical valve replacement. Dr. Windecker discusses possible explanations and strategies to minimize stroke with surgeon Dr. Kappetein.
When is it appropriate to revascularize patients with stable ischemic heart disease? Dr. King walks through 2 typical cases outlining the data behind his decision-making.
At risk for SCA after PCI? No problem — insert an ICD, right? Not so fast. The rationale behind why you may not get reimbursed. What are the alternatives?
Antiplatelet options in ACS are expanding across the globe. Dr. Abizaid from Brazil and Dr. Gaxiola from Mexico discuss 2 ACS cases and the data behind their decision-making.
At risk for SCA after PCI? No problem — insert an ICD, right? Not so fast. The rationale behind why you may not get reimbursed. What are the alternatives?
A 68-year-old man with 1 prior CABG and AVR in 2005 presented with new-onset crescendo angina CCS class III. A myocardial perfusion imaging stress test revealed large anteroapical and moderate inferolateral ischemia. Cardiac catheterization on March 20, 2012 revealed 3-vessel CAD of stenosed SVG to OM1 with normal LV function and a normal aortic bioprosthesis. He underwent successful intervention of culprit mid and distal LAD using Xience V DES and Tryton BMS in D2 as part of the Tryton Bifurcation IDE Study. The treatment plan now is for PCI of SVG to OM1.